June 1, 2017
EFPIA Japan Chairman Ole Moelskov Bech The Japanese drug market is projected to shrink at a compound annual growth rate (CAGR) of -2.5% during the coming 10 years to 8 trillion yen in FY2026 if the so-called price maintenance premium...read more